{"name": "ViiV Healthcare",
 "permalink": "viiv-healthcare",
 "crunchbase_url": "http://www.crunchbase.com/company/viiv-healthcare",
 "homepage_url": "http://www.viivhealthcare.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "viiv.Communications@viivhealthcare.com",
 "phone_number": "+44 (0)20 8380 6200",
 "description": "",
 "created_at": "Tue Nov 30 05:30:27 UTC 2010",
 "updated_at": "Tue Nov 30 05:30:26 UTC 2010",
 "overview": "\u003Cp\u003EViiV Healthcare is a global specialist HIV company established in November 2009 by GlaxoSmithKline (NYSE: GSK) and Pfizer (NYSE: PFE) dedicated to delivering advances in treatment and care for people living with HIV. Our aim is to take a deeper and broader interest in HIV/AIDS than any company has done before and take a new approach to deliver effective and new HIV medicines as well as support communities affected by HIV.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[88,
       76],
      "assets/images/resized/0011/2225/112225v1-max-150x150.png"],
     [[88,
       76],
      "assets/images/resized/0011/2225/112225v1-max-250x250.png"],
     [[88,
       76],
      "assets/images/resized/0011/2225/112225v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [{"funding_round":
     {"round_code": "unattributed",
      "source_url": "http://www.masshightech.com/stories/2010/11/22/daily22-Idenix-HIVAIDs-treatment-trials-attract-20M-milestone-payment.html",
      "source_description": "Idenix HIV/AIDs treatment trials attract $20M milestone payment",
      "raised_amount": 20000000.0,
      "raised_currency_code": "USD",
      "funded_year": 2010,
      "funded_month": 11,
      "funded_day": 23,
      "company":
       {"name": "Idenix Pharmaceuticals",
        "permalink": "idenix-pharmaceuticals",
        "image":
         {"available_sizes":
           [[[150,
              49],
             "assets/images/resized/0011/2224/112224v1-max-150x150.png"],
            [[212,
              70],
             "assets/images/resized/0011/2224/112224v1-max-250x250.png"],
            [[212,
              70],
             "assets/images/resized/0011/2224/112224v1-max-450x450.png"]],
          "attribution": null}}}}],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "980 Great West Road ",
    "address2": "Brentford",
    "zip_code": "TW8 9GS",
    "city": "Middlesex",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}